155 related articles for article (PubMed ID: 10834937)
1. TGF-beta autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells.
Bouché M; Canipari R; Melchionna R; Willems D; Senni MI; Molinaro M
FASEB J; 2000 Jun; 14(9):1147-58. PubMed ID: 10834937
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
[TBL] [Abstract][Full Text] [Related]
3. Rapid activation and down-regulation of protein kinase C alpha in 12-O-Tetradecanoylphorbol-13-acetate-induced differentiation of human rhabdomyosarcoma cells.
Bouché M; Zappelli F; Polimeni M; Adamo S; Wetsel WC; Senni MI; Molinaro M
Cell Growth Differ; 1995 Jul; 6(7):845-52. PubMed ID: 7547506
[TBL] [Abstract][Full Text] [Related]
4. Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function.
Susarla R; Watkinson JC; Eggo MC
J Cell Physiol; 2007 Sep; 212(3):643-54. PubMed ID: 17458906
[TBL] [Abstract][Full Text] [Related]
5. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
6. Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta.
Shiou SR; Datta PK; Dhawan P; Law BK; Yingling JM; Dixon DA; Beauchamp RD
J Biol Chem; 2006 Nov; 281(45):33971-81. PubMed ID: 16959768
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
8. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
Wang J; Sergina N; Ko TC; Gong J; Brattain MG
J Biol Chem; 2004 Sep; 279(38):40237-44. PubMed ID: 15271980
[TBL] [Abstract][Full Text] [Related]
9. PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells.
Mauro A; Ciccarelli C; De Cesaris P; Scoglio A; Bouché M; Molinaro M; Aquino A; Zani BM
J Cell Sci; 2002 Sep; 115(Pt 18):3587-99. PubMed ID: 12186945
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines.
Guo M; Reiners JJ
Carcinogenesis; 2000 Jul; 21(7):1303-12. PubMed ID: 10874007
[TBL] [Abstract][Full Text] [Related]
11. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
Yoshizawa M; Miyazaki H; Kojima S
J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
[TBL] [Abstract][Full Text] [Related]
12. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
Jakowlew SB; Mariano JM; You L
Growth Factors; 1997; 14(2-3):177-97. PubMed ID: 9255608
[TBL] [Abstract][Full Text] [Related]
13. TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors.
Bouché M; Senni MI; Grossi AM; Zappelli F; Polimeni M; Arnold HH; Cossu G; Molinaro M
Exp Cell Res; 1993 Sep; 208(1):209-17. PubMed ID: 8395398
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B.
Guo M; Mathieu PA; Linebaugh B; Sloane BF; Reiners JJ
J Biol Chem; 2002 Apr; 277(17):14829-37. PubMed ID: 11815600
[TBL] [Abstract][Full Text] [Related]
15. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
16. Aprotinin, a Kunitz-type protease inhibitor, stimulates skeletal muscle differentiation.
Wells JM; Strickland S
Development; 1994 Dec; 120(12):3639-47. PubMed ID: 7529678
[TBL] [Abstract][Full Text] [Related]
17. TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II.
Gardner S; Alzhanov D; Knollman P; Kuninger D; Rotwein P
Mol Endocrinol; 2011 Jan; 25(1):128-37. PubMed ID: 21106882
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
[TBL] [Abstract][Full Text] [Related]
19. Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.
Lynch MA; Petrel TA; Song H; Knobloch TJ; Casto BC; Ramljak D; Anderson LM; DeGroff V; Stoner GD; Brueggemeier RW; Weghorst CM
Gene Expr; 2001; 9(4-5):157-71. PubMed ID: 11444526
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
